The University of Wisconsin-Madison is to lose one of its stem-cell leaders. R. Timothy Mulcahy will be leaving UW-Madison to become vice president of research at the University of Minnesota in February....
Entrepreneurs on the University of Wisconsin-Madison campus will have a new resource to help them navigate the process of starting a company and the many related centers on campus....
Third Wave Technologies has expanded its product pipeline and will seek FDA clearance for several products within the next few years, the company told investors and analysts on Thursday....
When last we met a week ago, we took a look at the PricewaterhouseCoopers quarterly report on venture capital investments in the U.S. for the third quarter of 2003. As part of this analysis, we look at VC activity in the life science sector as...
A large Wisconsin investment has drawn a St. Louis biotech company to the Milwaukee County Research Park. The company is targeting a type of debilitating genetic disease that is often fatal, using a new technique....
Madison, Wis. — Wisconsin Alumni Research Foundation has licensed three patents for developing a new drug that targets the underlying cause of glaucoma, a group of diseases that can lead to blindness. ...
Madison, Wis. — NimbleGen, a Madison biotech firm that played a leading role in determining the origins of the 2003 Severe Acute Respiratory Syndrome outbreak in Singapore has won $12.8 million in venture capital....
Californians have approved putting their state into further debt to fund stem-cell research. In election-day polling, 59 percent of California voters approved Proposition 71, which will provide $3 billion in research grants over the next decade....
Madison, Wis. — The Wisconsin Life Sciences and Venture Conference will feature research from 20 companies that could lead to clinical products....
Wisconsin-France partnership on drug purification — Business Filings speaks Spanish — Alliant suffers from mild weather — Steinhafels selects Citrix management tools...